FDA Approved: DOCETAXEL ANHYDROUS — Supplemental Application (Meitheal Pharmaceuticals Inc)

View source ↗

Summary

The FDA approved a supplemental application from Meitheal Pharmaceuticals to market docetaxel anhydrous as a generic chemotherapy drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• DOCETAXEL ANHYDROUS (DOCETAXEL ANHYDROUS)

Snippet

SUPPL AP for DOCETAXEL ANHYDROUS (DOCETAXEL ANHYDROUS)